P

Pierre Fabre

Allogeneic cell therapies development and commercialization

National Access Director - West

Sales & Account ManagementConfirmed live in the last 24 hours
Full-timeRemote in USA

About the Job

Requirements

  • A bachelor's degree is required; healthcare degrees or credentials are desirable.
  • Strong, pre-existing working experience with national and regional payers that manage medical and pharmacy benefit policy.
  • Deep knowledge of and experience with inpatient and outpatient reimbursement methodology, dynamics, and impacts to hospital access economics.
  • At least 10 years of biotech or pharmaceutical experience, including at least two years of direct experience in coverage and reimbursement dynamics of complex advanced therapies such as cell therapy, gene therapy, or radioligand therapy.

Responsibilities

  • Operate in compliance with all laws, regulations, and policies governing Pierre Fabre activities.
  • Facilitate urgent post-approval access to Tab-Cel by educating payer customers and treatment-center financial stakeholders about the product's value proposition.
  • Contribute to the US Value and Access Team by monitoring trends and policy changes, assessing their implications, and taking ownership of this expertise.
  • Seek opportunities for synergy and partnership to achieve Pierre Fabre and customer goals through active, transparent planning and customer engagement with cross-functional teams.
  • Enable payer coverage assessment for Tab-Cel through pre-approval information exchange and post-approval engagement with national and regional payers in the Commercial, Medicare, and VA sectors.
  • Support the overall access strategy through engagement with Federal Payers and Medicare fee-for-service.
  • Educate payers about the urgent unmet need and provide resources to establish a pathway to coverage in pre- and post-approval regulatory settings.
  • Identify appropriate payer stakeholders for the therapy and partner with payer colleagues to establish pathways for expedited case review.
  • Provide approved product education and health-economic information to payer and provider customers to communicate the product's value proposition.
  • Ensure financial and reimbursement confidence and communicate payer coverage to providers post-approval.
  • Partner with treatment sites and key stakeholders to educate them on reimbursement processes, coverage, and coding relevant to the therapy post-approval.
  • Liaise with external specialty-distributor counterparts to meet objectives and provide a high-quality experience for sites of care.
  • Proactively communicate payer coverage criteria to internal field teams and external site-of-care stakeholders.
  • Prepare potential treatment centers to be reimbursement-ready before and after anticipated approval.
  • Ensure providers and payers have timely access to information needed to navigate prior authorizations and negotiate single-case agreements, including coding, relevant policy, and setting-of-care considerations.
  • Serve as the primary field-team member responsible for educating sites of care about patient assistance programs.
  • Serve as the field expert on market-access issues related to trade policy and partner with payer-relations teams at sites of care to resolve coverage and reimbursement issues.
  • Travel domestically up to 30%.

Desired Qualifications

  • Experience with cell and gene therapy networks and medical director teams at payers managing cell-therapy products.
  • Strong presentation skills and executive presence.
  • Strong business acumen and hospital administrative expertise.
  • Cell, gene, or stem-cell-transplant service-line experience and established relationships with financial key opinion leaders at institutions.
  • Ability to work in a fast-paced, dynamic environment while maintaining cross-functional internal relationships and contributing to site-of-care account planning.
  • Experience with pharmacy and therapeutics committees and high-impact drug review processes at institutions.

About the Company

Pierre Fabre

Allogeneic cell therapies development and commercialization

Pierre Fabre Pharmaceuticals (US) develops and commercializes allogeneic cell therapies for oncology and rare diseases. It focuses on bringing next-generation, donor-derived cell therapies to patients with high unmet medical needs and deepens partnerships with biotech companies to advance products through clinical manufacturing and distribution in the US.

Company size
5,001-10,000
Company stage
Seed
Total funding
$13.8M
Headquarters
Toulouse, France
Founded
1951

Recently Posted Jobs

Explore more opportunities at Pierre Fabre

See more jobs